Article
Thrombomodulin Arg403Lys mutation impairs protein C activation and increases thrombosis risk.
Thrombosis research - 1 Aug 2025
Lai Zhe, Yuan Junwei, Li Fang, Zhou Shijie, Wu Xi, Chen Nifei, Wu Wenman, Ding Qiulan, Dai Jing, Hu Xiaobo, Wang Xuefeng, Lu Yeling
Abstract excerpt
Thrombomodulin (TM) is an important regulator in various physiological processes, including coagulation, fibrinolysis and inflammation. TM exerts its cofactor activities for protein C (PC) activation and thrombin-activatable fibrinolysis inhibitor (TAFI) activation through its binding with thrombin. Numerous studies have reported that mutations of TM are associated with thromboembolic diseases. Here we report a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
